{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:55:45Z","timestamp":1778860545258,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T00:00:00Z","timestamp":1486771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10067-017-3570-4","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T01:32:00Z","timestamp":1486776720000},"page":"1005-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Antonia","family":"Boman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Kokkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth","family":"\u00c4rlestig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Berglin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,11]]},"reference":[{"key":"3570_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442","journal-title":"Nat Rev Immunol"},{"key":"3570_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","volume":"113","author":"JJ Pinzone","year":"2009","unstructured":"Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ et al (2009) The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113:517\u2013525","journal-title":"Blood"},{"key":"3570_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM (2010) Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 233:301\u2013312","journal-title":"Immunol Rev"},{"key":"3570_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/ar3380","volume":"13","author":"T Braun","year":"2011","unstructured":"Braun T, Zwerina J (2011) Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther. 13:235","journal-title":"Arthritis Res Ther."},{"key":"3570_CR5","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00198-013-2334-5","volume":"24","author":"M Vis","year":"2013","unstructured":"Vis M, Guler-Yuksel M, Lems WF (2013) Can bone loss in rheumatoid arthritis be prevented? Osteoporos Int 24:2541\u20132553","journal-title":"Osteoporos Int"},{"key":"3570_CR6","doi-asserted-by":"crossref","unstructured":"Danks L, Komatsu N, Guerrini MM, Sawa S, Armaka M, Kollias G, et al. (2015) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2014-207137"},{"key":"3570_CR7","first-page":"1223","volume":"21","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y (2011) Anti-RANKL antibody for the treatment of rheumatoid arthritis. Clin Calcium 21:1223\u20131229","journal-title":"Clin Calcium"},{"key":"3570_CR8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","volume":"19","author":"KE Poole","year":"2005","unstructured":"Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW et al (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19:1842\u20131844","journal-title":"FASEB J"},{"key":"3570_CR9","doi-asserted-by":"publisher","first-page":"26770","DOI":"10.1074\/jbc.M504308200","volume":"280","author":"M Semenov","year":"2005","unstructured":"Semenov M, Tamai K, Xi H (2005) SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280:26770\u201326775","journal-title":"J Biol Chem"},{"key":"3570_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1136\/annrheumdis-2013-203345","volume":"72","author":"XX Chen","year":"2013","unstructured":"Chen XX, Baum W, Dwyer D, Stock M, Schwabe K, Ke HZ et al (2013) Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis 72:1732\u20131736","journal-title":"Ann Rheum Dis"},{"key":"3570_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/ard.2009.122325","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen SW, Haavardsholm EA, Boyesen P, Goll GL, Okkenhaug C, Gaarder PI et al (2010) Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs. Ann Rheum Dis 69:845\u2013850","journal-title":"Ann Rheum Dis"},{"key":"3570_CR12","doi-asserted-by":"publisher","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 7:R949\u2013R958","journal-title":"Arthritis Res Ther."},{"key":"3570_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s11926-013-0366-7","volume":"15","author":"R Kocijan","year":"2013","unstructured":"Kocijan R, Harre U, Schett G (2013) ACPA and bone loss in rheumatoid arthritis. Curr Rheumatol Rep 15:366","journal-title":"Curr Rheumatol Rep"},{"key":"3570_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3570_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"3570_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM Gestel van","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van \u2018t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum 39:34\u201340","journal-title":"Arthritis Rheum"},{"key":"3570_CR17","first-page":"1974","volume":"22","author":"A Larsen","year":"1995","unstructured":"Larsen A (1995) How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 22:1974\u20131975","journal-title":"J Rheumatol"},{"key":"3570_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/ard.2003.018457","volume":"64","author":"K Bruynesteyn","year":"2005","unstructured":"Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D (2005) Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 64:179\u2013182","journal-title":"Ann Rheum Dis"},{"key":"3570_CR19","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar2214","volume":"9","author":"H Kokkonen","year":"2007","unstructured":"Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S (2007) The PTPN22 1858C\/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 9:R56","journal-title":"Arthritis Res Ther."},{"key":"3570_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P et al (2012) High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 44:1336\u20131340","journal-title":"Nat Genet"},{"key":"3570_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559\u2013575","journal-title":"Am J Hum Genet"},{"key":"3570_CR22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/ard.2009.121764","volume":"69","author":"LHD Tuyl van","year":"2010","unstructured":"van Tuyl LHD, Voskuyl AE, Boers M, Geusens P, Landewe RBM, Dijkmans BAC et al (2010) Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11\u00a0years in rheumatoid arthritis. Ann Rheum Dis 69:1623\u20131628","journal-title":"Ann Rheum Dis"},{"key":"3570_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3899\/jrheum.080180","volume":"36","author":"SW Syversen","year":"2009","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landewe R, Gaarder PI, Odegard S et al (2009) Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. J Rheumatol 36:266\u2013272","journal-title":"J Rheumatol"},{"key":"3570_CR24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3899\/jrheum.090262","volume":"36","author":"SW Syversen","year":"2009","unstructured":"Syversen SW, Landewe R, van der Heijde D, Bathon JM, Boers M, Bykerk VP et al (2009) Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers. J Rheumatol 36:1769\u20131784","journal-title":"J Rheumatol"},{"key":"3570_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13075-015-0760-9","volume":"17","author":"AH Hensvold","year":"2015","unstructured":"Hensvold AH, Joshua V, Li W, Larkin M, Qureshi F, Israelsson L et al (2015) Serum RANKL levels associate with anti-citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate. Arthritis Res Ther 17:239","journal-title":"Arthritis Res Ther"},{"key":"3570_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/030097401316909567","volume":"30","author":"K Forslind","year":"2001","unstructured":"Forslind K, Vincent C, Serre G, Svensson B (2001) Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression. Scand J Rheumatol 30:221\u2013224","journal-title":"Scand J Rheumatol"},{"key":"3570_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G et al (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 65:453\u2013458","journal-title":"Ann Rheum Dis"},{"key":"3570_CR28","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/ard.2009.116384","volume":"69","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP et al (2010) The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Ann Rheum Dis 69:1110\u20131116","journal-title":"Ann Rheum Dis"},{"key":"3570_CR29","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791\u20131802","journal-title":"J Clin Invest"},{"key":"3570_CR30","first-page":"268","volume":"40","author":"DA Mehaney","year":"2015","unstructured":"Mehaney DA, Eissa M, Anwar S, El-Din SF (2015) Serum sclerostin level among Egyptian rheumatoid arthritis patients: relation to disease activity ,bone mineral density and radiological grading. Acta reumatologica portuguesa 40:268\u2013274","journal-title":"Acta reumatologica portuguesa"},{"key":"3570_CR31","first-page":"18421","volume":"6","author":"R Seror","year":"2016","unstructured":"Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A et al (2016) Increased Dickkopf-1 in recent-onset rheumatoid arthritis is a new biomarker of structural severity. Data from the ESPOIR Cohort Sci Rep 6:18421","journal-title":"Data from the ESPOIR Cohort Sci Rep"},{"key":"3570_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jc.2011-2152","volume":"97","author":"K Amrein","year":"2012","unstructured":"Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K et al (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 97:148\u2013154","journal-title":"J Clin Endocrinol Metab"},{"key":"3570_CR33","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10067-007-0745-4","volume":"26","author":"T Furuya","year":"2007","unstructured":"Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T et al (2007) Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin Rheumatol 26:2137\u20132141","journal-title":"Clin Rheumatol"},{"key":"3570_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/annrheumdis-2012-202184","volume":"72","author":"DP Rooy de","year":"2013","unstructured":"de Rooy DP, Yeremenko NG, Wilson AG, Knevel R, Lindqvist E, Saxne T et al (2013) Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann Rheum Dis 72:769\u2013775","journal-title":"Ann Rheum Dis"},{"key":"3570_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/1381612820666140825122525","volume":"21","author":"A Krabben","year":"2015","unstructured":"Krabben A, Huizinga TW, Mil AH (2015) Biomarkers for radiographic progression in rheumatoid arthritis. Curr Pharm Des 21:147\u2013169","journal-title":"Curr Pharm Des"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3570-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3570-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3570-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:34:50Z","timestamp":1568806490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3570-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3570-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,11]]}}}